Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,069 public trials 582 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Active, Not Recruiting

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

NCT04036305

Conditions: Anesthesia, Local, Cardiovascular Diseases, Collagen Diseases, +14 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.

NCT02909036

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

NCT05556720

Conditions: Blood Protein Disorders, COVID-19 Vaccines, Cardiovascular Diseases, +27 more
Locations: St Vincents Hospital Darlinghurst, New South Wales, Australia

Prince Of Wales Hospital Randwick, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Royal Brisbane and Womens Hospital Herston, Queensland, Australia

View all 13 locations

View Trial Details

Active, Not Recruiting

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

NCT06479954

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Pfizer Tokyo, Japan

View Trial Details

Active, Not Recruiting

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT03147885

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +35 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT03015896

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

NCT04537871

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +32 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

Mt. Sinai New York, United States

View Trial Details

Active, Not Recruiting

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

NCT05823571

Conditions: Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

NCT03672318

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions